Lipophilicity Assessment of Ruthenium(II)-Arene Complexes by the Means of Reversed-Phase Thin-Layer Chromatography and DFT Calculations by Shweshein, Khalil Salem A. M. et al.
Research Article
Lipophilicity Assessment of Ruthenium(II)-Arene Complexes
by the Means of Reversed-Phase Thin-Layer Chromatography
and DFT Calculations
Khalil Salem A. M. Shweshein,1 Filip AndriT,1 Aleksandra RadoiIiT,1 Matija Zlatar,2
Maja Gruden-PavloviT,1 Civoslav TešiT,1 and Dušanka MilojkoviT-Opsenica1
1 Faculty of Chemistry, University of Belgrade, Studentski Trg 12–16, P.O. Box 51, 11158 Belgrade, Serbia
2 Institute for Chemistry, Technology and Metalurgy, Center of Chemistry, University of Belgrade, Njegosˇeva 12,
11000 Belgrade, Serbia
Correspondence should be addressed to Dusˇanka Milojkovic´-Opsenica; dusankam@chem.bg.ac.rs
Received 29 August 2013; Accepted 28 October 2013; Published 22 January 2014
Academic Editors: C. Platas-Iglesias and S. Sultan
Copyright © 2014 Khalil Salem A. M. Shweshein et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
The lipophilicity of ten ruthenium(II)-arene complexes was assessed by reversed-phase thin-layer chromatography (RP-TLC)
on octadecyl silica stationary phase. The binary solvent systems composed of water and acetonitrile were used as mobile phase
in order to determine chromatographic descriptors for lipophilicity estimation. Octanol-water partition coefficient, log𝐾OW,
of tested complexes was experimentally determined using twenty-eight standard solutes which were analyzed under the same
chromatographic conditions as target substances. In addition, ab initio density functional theory (DFT) computational approach
was employed to calculate log𝐾OW values from the differences in Gibbs’ free solvation energies of the solute transfer from n-octanol
to water. A good overall agreement between DFT calculated and experimentally determined log𝐾OW values was established (R2 =
0.8024–0.9658).
1. Introduction
Apart from being important in material science and catalysis,
metal ions and their complexes play a significant role in the
vital functions of living organisms. Numerous applications of
metal-based compounds as both therapeutic and diagnostic
agents as well as mineral supplements were studied in
scope of relatively young but rapidly developing research
discipline named medicinal inorganic chemistry [1]. Metal
complexes have a long history of use as medicines with
cytostatic, antirheumatic, or anti-inflammatory properties.
Further, they have been used in treatment of cardiac and
many other diseases, while the anticancer activity of metal
complexes, especially of cisplatin related drugs, is of the
greatest importance [2].
In addition to the widely used platinum-based chemo-
therapeutic drugs such as cisplatin or carboplatin, numerous
non-platinum-based compounds were investigated as anti-
cancer agents [1, 2]. Among them various ruthenium com-
plexes attracted recent attention. Their anticancer activity,
as well as clinical toxicity, is clearly distinct from platinum
complexes [3–5]. Diversity of modes of action that involves
both extra- and intracellular processes was achieved through
interactions of ruthenium complexes with plasma proteins,
extracellular matrix collagens, actins on the cell surface,
regulatory enzymes in the plasma membranes or cytoplasm,
andDNA in the cell nucleus [6]. In addition, some ruthenium
complexes exhibit greater efficacy against cancer metasta-
sis than against primary tumors by modulating adhesion,
migration, invasion, proteolytic degradation of extracellular
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matrix, and new blood vessel formation. Over the last
thirty years the interest for various ruthenium complexes,
their synthesis and potential anticancer activity is constantly
increasing, among them ruthenium(II)-arene compounds
are being in the focus of research.
Our previous studies have been focused on synthe-
ses, characterization, and cytotoxic activity of series of
ruthenium(II)-arene compounds [7–9]. It has been shown
that the presence of arene ligand is crucial. It is involved
in several steps: it stabilizes the +2 ruthenium oxidation
state, affects the cell uptake, influences the interactions
with potential intracellular targets, and provides satisfactory
lipophilicity needed to cross the cell membrane.
Since the lipophilicity is one of the major parame-
ters affecting important biological processes that follow
drug intake such as adsorption, passage through mem-
branes, drug-receptor interactions, metabolism, and toxicity
of molecules [10], we have decided to put an emphasis on
the determination and estimation of lipophilicity of several
ruthenium(II)-arene complexes in the scope of the present
work.
Octanol-water partition coefficient (log𝐾OW) is a widely
accepted measure of lipophilicity and can be determined for
various compounds including metal complexes in several
ways. According to original “shake-flask” method, 𝐾OW is
defined as a concentration ratio of compound distributed
between n-octanol and aqueous phase. However, this time-
consuming method with many experimental limitations
has been replaced with chromatographic methods such as
reversed-phase thin-layer chromatography (RP-TLC) [11],
high-performance liquid chromatography (HPLC) in both,
isocratic and gradient elution modes [12, 13], microemulsion
electrokinetic chromatography (MEEKC) [14], and immobi-
lized artificial membrane chromatography (IAM) [15]. Also,
many software applications such as ALOGP, KOWIN, and
CLOGP that incorporate different calculation approaches
and algorithms have been frequently applied. However, these
commonly used programs for log𝐾OW estimation are not
suitable in the case of complex compounds simply because
the appropriate input of the central metal atom is usually
missing, therefore resulting in poor predictions [16].
While considerable effort has been devoted to studying
the log𝐾OW of organic compounds, to the best of our
knowledge, only few papers are dealing with the measure
of log𝐾OW of various complexes mostly by the means of
the shake-flask method, HPLC in various reversed-phase
modalities, and MEKC [16], probably because of the fact
that complex compounds exhibit a very intricate behavior
in liquid-liquid partitioning systems including HPLC that
requires a delicate approach [17].
However, despite its numerous advantages and long his-
tory of successful application for lipophilicity determination
of small organic molecules, modern high-performance thin-
layer chromatography is rarely used for log𝐾OW determina-
tion of complex compounds, except for a few cases [18].
On the other hand, modern computational approach to
the estimation of lipophilicity of metal complexes mostly
relies on quantitative structure property relationship studies
(QSPR) that establish quantitative models based on experi-
mentally determined log𝐾OW data and ab initio calculated
molecular descriptors, such as the case with numerous
platinum-based complexes [19, 20]. However, complete, reli-
able, and comparable data which correlate the log𝐾OW with
relevant properties and molecular descriptors are needed.
Molecular descriptors often reflect complex and multiple
physical interactions, and model should include as many
descriptors as possible, often leading to difficult and ambigu-
ous interpretation of the results. Another approach based on
ab-initio calculations is to estimate the free solvation energy
change for the solute transfer from n-octanol to pure aqueous
phase. Modern theoretical methods in quantum chemistry,
such as density functional theory (DFT), possess great pre-
dictive power and in conjunction with continuum solvation
models are proven to be very reliable in the determination
of the free energy of solvation [21]. It is noteworthy to
mention that advantages of DFT are particularly important
for transition metal compounds [22, 23], although they
are not always considered as innocent systems. Continuum
solvation models are efficient tools for studying solvent
effects on molecular structure, spectra, and energetics [24–
27] and have been used with success for determination of
partition coefficients [28], pKa values [29], redox potentials
[30], and so forth. Improvement of solvent models is active
area in research in computational chemistry, and models are
continually being improved and new versions and models
frequently appear [31]. From a great variety of solventmodels,
in this work the universal model proposed by Marenich et
al, based on Density (SMD) [32] is used due to the proven
accuracy for first-principle calculation of solvation energies
[33].
In the present work the attention was focused on the
application of RP-TLC as a simple, fast, and reliable tool
to determine log𝐾OW values of ten ruthenium(II)-arene
complexes with potential anticancer and antiproliferative
activity. Moreover, there is a serious lack of information
in the present literature about lipophilicity assessment of
complex compounds by the means of TLC. In order to assure
accuracy of the proposed methodology we have employed
ab-initio DFT computational approach to calculate log𝐾OW
values from the differences in Gibbs’ free solvation energies
of the solute transfer from n-octanol to water and to compare
estimated values with experimentally determined ones.
Being simple, fast and reliable RP-TLC provides retention
data in the form of 𝑅
𝐹
and corresponding 𝑅
𝑀
values ((1)
and (2)) that can be further used to derive several chromato-
graphic descriptors for lipophilicity estimation: 𝑅0
𝑀
, 𝑏, 𝐶
0
,
and PC1. Consider the following:
𝑅
𝐹
=
𝑥
𝑓
. (1)
Parameters 𝑥 and𝑓 representmigration distance of the solute
and solvent front, respectively. Consider the following:
𝑅
𝑀
= log( 1
𝑅
𝐹
− 1) , (2)
𝑅
𝑀
= 𝑅
0
𝑀
+ 𝑏𝜑. (3)
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The first parameter (𝑅0
𝑀
) represents the intercept in the
linear relation between retention of a solute, 𝑅
𝑀
, and volume
fraction of organic-mobile-phase modifier, 𝜑 (3). As a value
extrapolated to 0% v/v of organic solvent it accounts for
partitioning of a solute between pure water and the nonpolar
stationary phase [34].
Slope, 𝑏, indicates the rate at which the solubility of the
solute increases with changes in the mobile-phase compo-
sition and it is related to the specific hydrophobic surface
area of a solute molecule [35]. Parameter 𝐶
0
, introduced by
Bieganowska et al. [36], represents the ratio of 𝑅0
𝑀
and 𝑏 and
is considered as a concentration of organic modifier in the
mobile phase for which the distribution of the solute between
the two phases is equal.
The last descriptor, the first principal component, PC1,
is derived from principal component analysis (PCA), that is,
principal component regression (PCR), multivariate chemo-
metric methods often applied on chromatographic data.
It has been demonstrated that the scores of the principal
components (usually the PC1 scores are sufficient) are better
correlated with log𝐾OW since PCA combines all chromato-
graphic data in one single feature [37].
2. Experimental
2.1. Materials. All reagents and solvents, including standard
substances, were of analytical or HPLC purity grade. They
are purchased from commercial suppliers: Aldrich (Mil-
waukee, WI, USA), Fluka (Buchs, Switzerland), and Merck
(Darmstadt, Germany), and used as received. Ruthenium(II)-
arene complex compounds (Figure 1) were synthesized and
characterized as already described [7, 8].
In the present work a set of 28 standard solutes, mainly
mono- and polysubstituted phenols, aromatic carboxylic
acids, ketones, amines, esters, and few polyaromatic hydro-
carbons, of known log𝐾OW values (Table 1) were chosen
for calibration. Experimentally determined values of log𝐾OW
were taken from the KOWWIN software (EPI Suite, v. 4.11
US EPA). The set of standard compounds was compiled con-
sidering that hydrogen bonds, for both proton accepting and
proton donating, as well as dipolar interactions, among the
overall interactions that solutes exhibit in a chromatographic
environment, should be present in a way as to ensure the
ability of the final model to describe the behavior of a diverse
set of compounds. The optimal range of log𝐾OW values was
considered broad enough to provide a reliable regression per-
formance (from 1 to 5 log𝐾OW units). Dissociation constants
for ionogenic compoundswere collected from several sources
and presented along with the calculated degree of ionization
(𝛼) at pH = 6 in Table 1.
2.2. Chromatographic Procedure. For all chromatographic
experiments solutions of standard substances, as well as of
studied ruthenium complex compounds, were prepared by
dissolving appropriate amount of substance in acetone in
concentration of 0.1mg/mL. Commercially available octade-
cyl modified silica aluminum sheets (Art. number 5559,
Merck, Darmstadt, Germany) were cut into 10×10 cm plates.
Table 1: Calibration set of standard compoundswith experimentally
determined log𝐾OW values.
No. Compound log𝐾OW p𝐾𝑎
𝛼 Ionization
degree (%)
1 1,2,3-Benzotriazole 1.44 8.37 0.42
2 4-Chlorobenzoic acid 2.65 3.98 99.05
3 2-Nitrobenzaldehyde 1.74 — —
4 4-Bromoaniline∗ 2.26 3.86 99.28∗
5 Phenol 1.46 10.09 0.01
6 Benzophenone 3.18 — —
7 3-Nitrobenzaldehyde 1.46 — —
8 4-Aminobenzoic acid 0.83 4.65 95.72
9 Phthalimide∗ 1.15 100.00∗
10 1,4-Benzoquinone 0.20 — —
11 4-Nitrophenol 1.91 7.15 6.61
12 3-Nitrophenol 2.00 8.28 0.52
13 Benzyl alcohol 1.10 — —
14 Naphthylamine∗ 2.25 3.92 99.18∗
15 2-Naphthol 2.85 9.67 0.02
16 4-Fluoroaniline∗ 1.15 4.70 95.23∗
17 1-Naphthol 2.85 9.34 0.05
18 4-Hydroxybenzaldehyde 1.35 — —
19 3-Chloronitrobenzene 2.46 — —
20 2,4-Dichlorophenol 3.06 7.85 1.39
21 4-Methylphenol 1.94 10.09 0.01
22 4-Chlorophenol 2.39 9.38 0.04
23 Anthracene 4.45 — —
24 Acetophenone 1.58 — —
25 2-Aminophenol 0.62 9.44 0.04
26 4-t-Butylphenol 3.31 10.31 0.00
27 1,3,5-Trihydroxybenzene 0.16 9.40 0.04
28 2,6-Dimethylphenol 2.36 10.59 0.00
∗Calculated to the corresponding protonated conjugated acid.
The plates were manually spotted with approximate volume
of 1.0 𝜇L of freshly prepared solutions, at 5mm distance from
each edge of the plate. Mixtures of acetonitrile and water
were used as mobile phases, with organic component content
increasing in the range of 30–60% v/v, with increment of
5%. Other organic modifiers such as methanol and acetone
have been tested, but some of the ruthenium complexes
were either moved through the system nonselectively or
completely retained at the starting points.They are, therefore,
discarded from the further study. The chromatograms were
developed using horizontal developing chamber (CAMAG,
Mutenz, Switzerland). The solvent migration distance was
about 4.5 cm. The plates were visually inspected under the
UV light (254 nm) and each zone was clearly marked and
its distance was manually measured. All measurements were
done in triplicate and average values were used in further
calculations. All experiments were performed at ambient
temperature (22 ± 2∘C).
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Figure 1: Structures of studied ruthenium(II)-arene complexes.
2.3. Calculation of Chromatographic Descriptors. The fol-
lowing chromatographic descriptors: 𝑅0
𝑀
, 𝑏, and 𝐶
0
, were
calculated based on the retention data (Table 2). 𝑅0
𝑀
and
𝑏 were obtained as the intercept and slope, respectively,
according to (3). The hydrophobicity parameter 𝐶
0
was
calculated as the ratio (−𝑅0
𝑀
/𝑏). However, this parameter did
not show promising retention—log𝐾OW models, and was
excluded from the further study. All necessary calculations
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Table 2: Retention of standard compounds and studied ruthenium complexes given as 𝑅
𝐹
values.
Number Compound Volume fraction of acetonitrile (%)
30 35 40 45 50 55 60
1 1,2,3-Benzotriazole — — 0.31 0.39 0.48 0.51 0.53
2 4-Chlorobenzoic acid — — 0.13 0.16 0.22 0.24 0.38
3 2-Nitrobenzaldehyde — — 0.11 0.14 0.21 0.24 0.30
4 4-Bromoaniline — — 0.06 0.08 0.15 0.18 0.25
5 Phenol — — 0.26 0.33 0.40 0.50 0.57
6 Benzophenone — — 0.03 0.05 0.07 0.09 0.15
7 3-Nitrobenzaldehyde — — 0.11 0.14 0.23 0.24 0.30
8 4-Aminobenzoic acid — — 0.44 0.48 0.54 0.56 0.60
9 Phthalimide — — 0.24 0.30 0.41 0.43 0.48
10 1,4-Benzoquinone — — 0.40 0.43 0.49 0.50 0.52
11 4-Nitrophenol — — 0.24 0.28 0.33 0.46 0.52
12 3-Nitrophenol — — 0.16 0.20 0.27 0.41 0.49
13 Benzyl alcohol — — 0.42 0.50 0.53 0.59 0.64
14 Naphthylamine — — 0.12 0.16 0.22 0.33 0.41
15 2-Naphthol — — 0.13 0.18 0.27 0.37 0.43
16 4-Fluoroaniline — — 0.26 0.28 0.36 0.48 0.52
17 1-Naphthol — — 0.12 0.13 0.19 0.33 0.39
18 4-Hydroxybenzaldehyde — — 0.41 0.39 0.48 0.61 0.63
19 3-Chloronitrobenzene — — 0.07 0.09 0.11 0.22 0.28
20 2,4-Dichlorophenol — — 0.09 0.12 0.27 0.33 0.40
21 4-Methylphenol — — 0.26 0.30 0.36 0.48 0.54
22 4-Chlorophenol — — 0.17 0.24 0.30 0.39 0.51
23 Anthracene — — 0.01 0.02 0.02 0.09 0.15
24 Acetophenone — — 0.23 0.26 0.31 0.41 0.51
25 2-Aminophenol — — 0.42 0.42 0.51 0.62 0.66
26 4-t-Butylphenol — — 0.07 0.09 0.16 0.28 0.39
27 1,3,5-Trihydroxybenzene — — 0.73 0.67 0.77 0.80 0.84
28 2,6-Dimethylphenol — — 0.11 0.16 0.23 0.33 0.41
29 Ru-1 0.01 0.01 0.02 0.04 0.06 0.11 —
30 Ru-2 0.00 0.01 0.02 0.04 0.06 0.12 —
31 Ru-3 0.01 0.01 0.02 0.04 0.06 0.15 —
32 Ru-4 0.01 0.02 0.05 0.07 0.10 0.14 —
33 Ru-5 0.01 0.03 0.06 0.08 0.13 0.16 —
34 Ru-6 0.08 0.13 0.19 0.24 0.31 0.37 —
35 Ru-7 0.23 0.28 0.32 0.37 0.44 0.49 —
36 Ru-8 0.11 0.15 0.23 0.27 0.33 0.45 —
37 Ru-9 0.05 0.07 0.13 0.16 0.21 0.29 —
38 Ru-10 0.02 0.04 0.07 0.11 0.19 0.24 —
were performed using the Data analysis tool-pack (Microsoft
Excel 2010). The obtained models are summarized in Table 3
followed by accompanying statistics.
2.4. Modeling and Validation of TLC Retention—log𝐾OW
Relationship. Calibration models based on individual 𝑅
𝑀
values as well as extrapolated 𝑅0
𝑀
and 𝑏 descriptors were
established using standard set of compounds (Table 1) and
ordinary least squares procedure (Data analysis tool-pack,
Microsoft Excel 2010). Principal component regression was
employed instead of separate calculation of PC1 score values,
using singular value decomposition (SVD) algorithm, fol-
lowed by random subset cross-validation (five splits and one
iteration) procedure. All calculations were made with PLS
Tool Box v. 7.2., (Eigenvectors Research Inc.) for MATLAB
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Table 3: Linear relationship between solute retention (𝑅
𝑀
) and organic modifier volume fraction (𝜑). Accompanied statistics (R: Pearson’s
correlation coefficient, F: Fisher’s parameter, S.D.: model standard deviation, n: number of calibration points) with values of intercept (𝑅0
𝑀
)
and slope (−𝑏).
Compound Chromatographic parameters
𝑅
0
𝑀
−𝑏 R S.D. F n
1,2,3-Benzotriazole 1.13 ± 0.16 2.05 ± 0.32 0.9642 0.052 39.65 5
4-Chlorobenzoic acid 1.98 ± 0.18 2.83 ± 0.36 0.9770 0.056 62.92 5
2-Nitrobenzaldehyde 1.99 ± 0.11 2.73 ± 0.22 0.9901 0.035 149.91 5
4-Bromoaniline 2.74 ± 0.19 3.81 ± 0.38 0.9858 0.059 103.48 5
Phenol 1.64 ± 0.05 2.94 ± 0.11 0.9981 0.017 768.73 5
Benzophenone 2.86 ± 0.11 3.42 ± 0.23 0.9935 0.036 229.29 5
3-Nitrobenzaldehyde 1.98 ± 0.20 2.73 ± 0.39 0.9707 0.062 48.96 5
4-Aminobenzoic acid 0.65 ± 0.07 1.38 ± 0.14 0.9848 0.022 96.39 5
Phthalimide 1.40 ± 0.18 2.32 ± 0.35 0.9671 0.056 43.29 5
1,4-Benzoquinone 0.61 ± 0.08 1.10 ± 0.15 0.9723 0.024 51.88 5
4-Nitrophenol 1.66 ± 0.13 2.83 ± 0.25 0.9886 0.039 129.19 5
3-Nitrophenol 2.22 ± 0.15 3.67 ± 0.30 0.9900 0.048 147.99 5
Benzyl alcohol 0.87 ± 0.07 1.86 ± 0.13 0.9924 0.021 195.84 5
Naphthylamine 2.40 ± 0.08 3.75 ± 0.15 0.9976 0.024 612.44 5
2-Naphthol 2.30 ± 0.10 3.70 ± 0.21 0.9954 0.033 323.64 5
4-Fluoroaniline 1.56 ± 0.16 2.68 ± 0.32 0.9789 0.051 68.73 5
1-Naphthol 2.44 ± 0.23 3.75 ± 0.46 0.9785 0.072 67.56 5
4-Hydroxybenzaldehyde 1.16 ± 0.25 2.33 ± 0.49 0.9396 0.078 22.59 5
3-Chloronitrobenzene 2.67 ± 0.25 3.75 ± 0.50 0.9747 0.078 57.07 5
2,4-Dichlorophenol 2.73 ± 0.30 4.35 ± 0.60 0.9728 0.095 52.89 5
4-Methylphenol 1.61 ± 0.10 2.80 ± 0.194 0.9928 0.031 207.53 5
4-Chlorophenol 2.10 ± 0.08 3.49 ± 0.16 0.9969 0.025 487.62 5
Anthracene 4.37 ± 0.50 5.96 ± 0.98 0.9616 0.155 36.87 5
Acetophenone 1.66 ± 0.15 2.75 ± 0.29 0.9836 0.046 89.03 5
2-Aminophenol 1.15 ± 0.19 2.37 ± 0.37 0.9657 0.059 41.45 5
4-t-Butylphenol 3.16 ± 0.17 4.93 ± 0.35 0.9927 0.055 204.43 5
1,3,5-Trihydroxybenzene 0.38 ± 0.29 1.79 ± 0.57 0.8754 0.090 9.84 5
2,6-Dimethylphenol 2.41 ± 0.06 3.77 ± 0.13 0.9984 0.020 908.70 5
Ru-1 3.90 ± 0.32 5.45 ± 0.74 0.7903 0.155 6.65 6
Ru-2 3.97 ± 0.22 5.71 ± 0.51 0.8797 0.106 13.69 6
Ru-3 3.96 ± 0.16 5.75 ± 0.38 0.8263 0.079 8.61 6
Ru-4 3.24 ± 0.32 4.56 ± 0.74 0.9351 0.154 27.86 6
Ru-5 3.20 ± 0.30 4.69 ± 0.69 0.8732 0.145 12.84 6
Ru-6 1.97 ± 0.08 3.24 ± 0.18 0.9564 0.037 42.93 6
Ru-7 1.13 ± 0.08 2.02 ± 0.19 0.9875 0.039 157.10 6
Ru-8 1.88 ± 0.14 3.22 ± 0.31 0.9563 0.066 42.81 6
Ru-9 2.35 ± 0.17 3.58 ± 0.40 0.9010 0.084 17.25 6
Ru-10 3.04 ± 0.14 4.73 ± 0.31 0.9824 0.066 110.36 6
R2011a (Mathworks Inc.). Quality of obtained models was
assessed by the means of Pearson’s 𝑅2 and accompanying
statistics.
2.5. DFT Computational Details. The common logarithm of
𝐾OW is calculated as
log𝐾OW =
Δ𝐺sol(water) − Δ𝐺sol(oct)
2.303𝑅𝑇
, (4)
where Δ𝐺sol is the standard state solvation free energy of a
given complex in octanol (oct) or in water (water) at 𝑇 =
298K. The standard-state solvation free energy is defined
as the free energy of transfer from the gas phase to the
condensed phase under standard state conditions. Because
the gas-phase free energies are calculated with respect to a
standard state of 1 atm, a correction factor of 𝑅𝑇 ln(24.46)
(1.894 kcalmol−1 at 298K) needs to be added to convert it into
the standard state of 1mol dm−3.
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Table 4: Calibration models and accompanying statistics.
Model
number Model type Equation Statistics
1 OLS 𝑅
𝑀40% = (−0.17 ± 0.09) + (0.44 ± 0.04) log𝐾OW 𝑅
2
= 0.8067, S.D. = 0.22, 𝑃 < 10−4, 𝑛 = 28
2 OLS 𝑅
𝑀45% = (−0.17 ± 0.08) + (0.38 ± 0.04) log𝐾OW 𝑅
2
= 0.7882, S.D. = 0.20, 𝑃 < 10−4, 𝑛 = 28
3 OLS 𝑅
𝑀50% = (−0.32 ± 0.09) + (0.37 ± 0.04) log𝐾OW 𝑅
2
= 0.7666, S.D. = 0.20, 𝑃 < 10−4, 𝑛 = 28
4 OLS 𝑅
𝑀55% = (−0.34 ± 0.09) + (0.29 ± 0.04)log𝐾OW 𝑅
2
= 0.6521, S.D. = 0.15, 𝑃 < 10−4, 𝑛 = 28
5 OLS 𝑅0
𝑀
= (0.3 ± 0.2) + (0.83 ± 0.06) log𝐾OW 𝑅
2
= 0.8857, S.D. = 0.33, 𝑃 < 10−4, 𝑛 = 28
6 OLS 𝑏 = (1.2 ± 0.2) + (0.98 ± 0.08) log𝐾OW 𝑅
2
= 0.8388, S.D. = 0.31, 𝑃 < 10−4, 𝑛 = 28
7 PCR log𝐾OW = 0.58 𝑅𝑀40% +0.63 𝑅𝑀45% +0.62 𝑅𝑀50% −0.95 𝑅𝑀55%
RMSEC = 0.375; 𝑅2Cal = 0.8502
RMSECV= 0.418; 𝑅2CV = 0.8146
Table 5: Selected average bond lengths (A˚) and valence angles (∘) for available crystallographic data (a) and comparison with DFT energy-
minimized structures (b).
Comp. Bond lengths (A˚) Valence angles (
∘)
M–C M–Cl M–N M–O O–M–N O–M–Cl N–M–Cl Cl–M–Cl
Ru-1
a 2.18 2.40 2.13 — — — 86.0 87.0
b 2.19 2.37 2.05 — — — 84.8 88.7
Ru-7
a 2.18 2.41 2.10 2.10 77.9 86.7 85.3 —
b 2.19 2.37 2.03 2.04 78.8 88.6 81.9 —
Ru-9
a 2.19 2.40 2.16 2.09 76.9 83.7 85.2 —
b 2.18 2.37 2.04 2.03 79.1 86.6 82.8 —
Ru-10
a 2.19 2.42 2.10 2.09 78.0 85.2 85.2 —
b 2.18 2.37 2.04 2.03 79.1 86.6 82.8 —
All the DFT calculations have been carried out with the
Gaussian 09, revision C.01 electronic structure program suite
[38]. The local density approximation characterized by the
Vosko-Wilk-Nusair (SVWN5) parametrization [39] has been
used for the gas phase geometry optimizations, proven to be
accurate for geometries of Werner type complexes [40–42].
The rutheniumcationwas described by LANL2DZ relativistic
effective core potentials (ECP) that replace 28 core electrons
with a nonlocal effective potential and associated basis set for
remaining electrons [43]. 6-31G+(d,p) basis set [44] was used
for all other atoms. For the determination of log𝐾OW, M06L
density functional [45, 46], with the ECP LANL2TZ basis set
[47] for ruthenium, and 6-311+G(2d,p) for other atoms were
used. The free energies of solvation were calculated using
continuum solvation model based on density (SMD) [32].
With SMD, the 298K solvation Gibbs energy is defined as
the difference between the solvent and gas electronic energies
[48], necessitating corresponding gas-phase calculation.
3. Results and Discussion
For all studied compounds a good linearity between retention
constants (𝑅
𝑀
) and the volume fraction of acetonitrile
was obtained resulting in well-established chromatographic
descriptors (𝑅0
𝑀
and 𝑏) (Table 3), even in the case of strongly
polar or ionizable compounds as well as highly hydrophobic
solutes. Although 𝐶
0
was initially calculated, this parameter
was later excluded from further consideration, because of
statistically significant, but poor, correlation with log𝐾OW
values (𝑅2 = 0.4978, 𝑃 < 10−4).
All calibration models were obtained using entire set of
standard compounds. Accompanying statistics and equations
are summarized in Table 4. Depending on the particular
model, some of standard compounds were identified as
outliers, with borderline statistical significance. However, all
data were kept because of lack of reasonable justification
for outlier removal. The best model was achieved using
𝑅
0
𝑀
parameter (𝑅2 = 0.8857), while direct calibration of
retention in 55% acetonitrile-water system (model no. 4)
showed the worst correlation (𝑅2 = 0.6521). There is obvious
deterioration in statistical performance of calibration models
based on𝑅
𝑀
values with an increase of acetonitrile content in
mobile phase; however, with exception of the model number
4, no model can be statistically justified as being preferred
over the others. Use of direct calibration is more convenient
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Table 6: Chromatographically determined and computationally estimated log𝐾OW values of studied ruthenium complexes.
Comp.
Chromatographically determined Estimated
Model number Based on ab initio (DFT) computations
1 2 3 4 5 6 7 Δ𝐺sol (oct)(kcal/mol)
Δ𝐺sol (water)
(kcal/mol) log𝐾OW
Ru-1 4.26 ± 0.37 4.03 ± 0.38 4.19 ± 0.42 4.31 ± 0.56 4.31 ± 0.28 4.38 ± 0.34 3.72 −13.85 −19.81 4.36
Ru-2 4.13 ± 0.37 3.91 ± 0.37 4.09 ± 0.41 4.13 ± 0.55 4.39 ± 0.28 4.63 ± 0.35 3.65 −13.27 −19.35 4.45
Ru-3 4.13 ± 0.37 3.91 ± 0.37 4.09 ± 0.41 3.74 ± 0.52 4.38 ± 0.28 4.68 ± 0.36 3.97 −9.99 −17.63 5.59
Ru-4 3.42 ± 0.33 3.43 ± 0.35 3.50 ± 0.38 3.86 ± 0.52 3.52 ± 0.25 3.47 ± 0.30 2.91 −14.48 −19.60 3.75
Ru-5 3.18 ± 0.32 3.24 ± 0.34 3.08 ± 0.36 3.63 ± 0.51 3.47 ± 0.24 3.59 ± 0.30 2.63 −14.99 −19.97 3.65
Ru-6 1.81 ± 0.30 1.72 ± 0.32 1.81 ± 0.34 1.99 ± 0.45 2.00 ± 0.22 2.11 ± 0.27 1.63 −20.77 −23.24 1.81
Ru-7 1.15 ± 0.31 1.07 ± 0.33 1.15 ± 0.35 1.24 ± 0.46 0.98 ± 0.23 0.87 ± 0.28 1.14 −20.51 −22.57 1.50
Ru-8 1.61 ± 0.30 1.59 ± 0.32 1.68 ± 0.34 1.49 ± 0.45 1.88 ± 0.22 2.09 ± 0.27 1.78 −19.35 −21.61 1.66
Ru-9 2.33 ± 0.30 2.36 ± 0.32 2.39 ± 0.34 2.55 ± 0.46 2.44 ± 0.22 2.46 ± 0.27 2.14 −16.88 −19.70 2.06
Ru-10 2.99 ± 0.32 2.80 ± 0.33 2.56 ± 0.34 2.87 ± 0.47 3.27 ± 0.24 3.63 ± 0.31 2.59 −15.64 −19.15 2.57
compared to calculation of 𝑅0
𝑀
, 𝑏, and PCR since it does
not require additional experimental and computational work.
However, 𝑅0
𝑀
and 𝑏 can be assessed for both highly lipophilic
and polar compounds that exhibit measurable retention
(0.2 < 𝑅
𝐹
< 0.8) in different range of organic modifier
volume ratios, in contrast to direct calibration based on
isocratic chromatographic conditions. Because of its physical
meaning, 𝑅0
𝑀
parameter might be the most suitable.
The calculated gas-phase geometries of all complexes
under investigation are in excellent agreement with available
X-ray crystal structures [7, 8] (Table 5).
Chromatographically determined log𝐾OW values were
obtained using retention data (Table 2) and established
calibrationmodels (Table 3). Data are summarized in Table 6.
All estimation methods (models 1–7) give mutually coherent
data, with no statistical difference in between. Also there
is a good overall agreement between DFT calculated and
experimentally determined values (𝑅2 = 0.8024–0.9658).
Studied ruthenium(II)-arene complexes exhibit unusu-
ally high lipophilicity, in the range of 1–4 log units, com-
pared with reported log𝐾OW values of different series of
platinum(II) and platinum(IV) complexes [19, 20] as well as
with someRu-(𝜂6-arene) compounds of similar structure that
show significantly low octanol-water distribution coefficients
[49]. However, all mentioned compounds have been posi-
tively charged, which might explain their low lipophilicity in
comparison with neutral complexes investigated in current
study.
4. Conclusion
The lipophilicity of ten ruthenium(II)-arene complexes with
potential anticancer and antiproliferative activity has been
determined by means of RPTLC on RP-18 silica as stationary
and binary acetonitrile-water solvent systems as mobile
phase. Based on retention data corresponding chromato-
graphic descriptors for lipophilicity assessment have been
obtained. Most of the experimental findings described above
have been confirmed byDFT free energy calculations of com-
plexes in octanol andwater as solvents, using solvationmodel
based on density (SMD). As results are promising, it can
be considered as reliable tool for prediction of lipophilicity
and rational design of coordination compounds with desired
properties.
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